Delivery Order SPE2DB20D2014-SPE2DB25FB95U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,729.55 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes, with an ultimate completion date of December 10, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded on a competitive basis. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,697.07 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes with a firm fixed price. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and involves no set-aside designation. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $12,084.12 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/mL syringes, valued at $9,104.04 under firm fixed price terms. The award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $7,575.13 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Prolia 60 mg/ml syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The delivery is scheduled for completion by October 23, 2025, with performance taking place at...
- The Defense Logistics Agency awarded a delivery order valued at $32,625.43 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 20, 2025. This is a firm fixed-price, non-set-aside contract executed on August 19, 2025, with performance to take place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,746.68 for Prolia 60 mg/ml syringes on June 25, 2025, with an ultimate completion date of June 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $16,071.75 to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,258.28 to AmerisourceBergen Drug Corp for Prolia 60mg/ml syringes on December 11, 2025, with completion scheduled for December 12, 2025. This firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $8,571.60 delivery order to AmerisourceBergen Drug Corp for Prolia 60 mg/ml syringes, with an ultimate completion date of November 6, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FB95UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,285.80 to AmerisourceBergen Drug Corp for the supply of Prolia 60 mg/ml syringes. The award, issued on May 15, 2025, with an ultimate completion date of May 16, 2025, was made under firm fixed price terms with no set-aside designation, indicating competitive award. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, serves as a prime contractor for the Defense Logistics Agency's medical supply chain. The company supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Prolia—an osteoporosis treatment—exemplifies the routine pharmaceutical procurement activity conducted under the larger global pharmaceutical support vehicle that enables AmerisourceBergen to supply federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 5/15/25 |